Viragen Inc start expand study alpha interferon topical ointment treatment genital herpes. It conduct phase III study dosage form treatment compare placebo nonmedicated substitute 154 women. Viragen study result expect October 1987. Viragen prepared submit license application ointment England Canada West Germany addition U.S. phase III study completed. Reuter 